Metastatic Breast Cancer


FDA approves new treatment for certain advanced or metastatic breast cancers (10-5-2017)

The U.S. Food and Drug Administration today approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed... Continue Reading

No Benefit with Addition of Onartuzumab to Taxol® with or without Avastin® in Triple-Negative Breast Cancer (09-29-2015)

The addition of the targeted therapy onartuzumab to Taxol® (paclitaxel) with or without Avastin® (bevacizumab) does not appear to help control disease or improve survival in patients with metastatic triple-negative breast cancer. These findings were... Continue Reading

Afinitor Provides Benefit in Advanced, HER2-Positive Breast Cancer (06-28-2013)

Among women with advanced HER2-positive breast cancer and resistance to Herceptin® (trastuzumab), a treatment regimen that included Afinitor® (everolimus) delayed cancer progression. The results of this Phase III clinical trial were presented at the... Continue Reading

Diagnosis of Early Breast Cancer Doesn’t Shorten Life Expectancy of Older Women (03-28-2011)

Among women age 67 or older, a diagnosis of ductal carcinoma in situ (DCIS) or Stage I breast cancer doesn’t appear to worsen survival; survival is similar to that of older women without breast cancer. Diagnosis of more advanced breast cancer, however,... Continue Reading

Social Support May Improve Breast Cancer Outcomes (01-26-2011)

Social well-being during the first year after a breast cancer diagnosis may have a beneficial effect on cancer outcomes. These results were published in the Journal of Clinical Oncology. A diagnosis of breast cancer often affects a woman’s quality of... Continue Reading

Xgeva Approved for Patients with Bone Metastases (11-30-2010)

Xgeva™ (denosumab) has been approved by the US Food and Drug Administration (FDA) for the prevention of bone complications such as fracture in patients with bone metastases from solid (not blood-related) cancers. It is not approved for patients with... Continue Reading

Number of Circulating Cancer Cells Associated with Survival in Advanced Breast Cancer (10-30-2008)

Number of Circulating Cancer Cells Associated with Survival in Advanced Breast Cancer Cancer cells found circulating in the blood are a strong predictor of mortality among patients with metastatic breast cancer. Patients with large numbers of cancer... Continue Reading

Aromasin® and Nolvadex® Both Effective as Initial Therapy for Hormone-Positive Breast Cancer (10-22-2008)

Aromasin® and Nolvadex® Both Effective as Initial Therapy for Hormone-Positive Breast Cancer Both Aromasin (exemestane) and Nolvadex (tamoxifen) are effective as initial therapy for metastatic breast cancer among postmenopausal women. These results... Continue Reading